 By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT Initiating Coverage Novan, Inc. NASDAQ:NOVN is currently pursuing an indication in molluscum contagiosum MC, a contagious skin condition that generally affects young children. Novan recently completed two Phase III trials for their lead candidate in the disease; however, while the results were directionally favorable, 